Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D5TN
|
|||
| Former ID |
DIB012165
|
|||
| Drug Name |
TT-034
|
|||
| Synonyms |
BLT-HCV; OBP-701; RNAi therapy (hepatitis C virus infection); TT-033; TT-033i; DdRNAi therapy (HCV), Benitec; RNAi therapy (HCV), Benitec; RNAi therapy (hepatitis C virus infection), Tacere/ Pfizer
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 1/2 | [1] | |
| Company |
Benitec Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H16ClN5
|
|||
| Canonical SMILES |
CC(C)CN1C(=NN=N1)C2=CC(=CC=C2)N.Cl
|
|||
| InChI |
1S/C11H15N5.ClH/c1-8(2)7-16-11(13-14-15-16)9-4-3-5-10(12)6-9;/h3-6,8H,7,12H2,1-2H3;1H
|
|||
| InChIKey |
QRFDPUUTKDZZIX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01899092) Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.